Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2017-2026

DUBLIN, April 19, 2018 /PRNewswire/ --

The "Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Diabetic Macular Edema epidemiology, Diabetic Macular Edema diagnosed patients, and Diabetic Macular Edema treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Diabetic Macular Edema derived from epidemiological analysis, patients diagnosed with Diabetic Macular Edema, and patients treated with a drug therapy.

The research study helps executives estimate Diabetic Macular Edema market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Diabetic Macular Edema prevalence, Diabetic Macular Edema diagnosis rate, and Diabetic Macular Edema treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Topics Covered:

1. Diabetic Macular Edema: Disease Definition

2. Global Diabetic Macular Edema Patient Flow

2A. Global Diabetic Macular Edema Prevalence

2B. Global Diabetic Macular Edema Diagnosed Patients

2C. Global Diabetic Macular Edema Treated Patients

3. Diabetic Macular Edema Patient Flow in the US

3A. Diabetic Macular Edema Prevalence in the US

3B. Diabetic Macular Edema Diagnosed Patients in the US

3C. Diabetic Macular Edema Treated Patients in the US

4. Diabetic Macular Edema Patient Flow in Europe

4A. Diabetic Macular Edema Prevalence in Europe

4B. Diabetic Macular Edema Diagnosed Patients in Europe

4C. Diabetic Macular Edema Treated Patients in Europe

5. Diabetic Macular Edema Patient Flow in Germany

5A. Diabetic Macular Edema Prevalence in Germany

5B. Diabetic Macular Edema Diagnosed Patients in Germany

5C. Diabetic Macular Edema Treated Patients in Germany

6. Diabetic Macular Edema Patient Flow in France

6A. Diabetic Macular Edema Prevalence in France

6B. Diabetic Macular Edema Diagnosed Patients in France

6C. Diabetic Macular Edema Treated Patients in France

7. Diabetic Macular Edema Patient Flow in Spain

7A. Diabetic Macular Edema Prevalence in Spain

7B. Diabetic Macular Edema Diagnosed Patients in Spain

7C. Diabetic Macular Edema Treated Patients in Spain

8. Diabetic Macular Edema Patient Flow in Italy

8A. Diabetic Macular Edema Prevalence in Italy

8B. Diabetic Macular Edema Diagnosed Patients in Italy

8C. Diabetic Macular Edema Treated Patients in Italy

9. Diabetic Macular Edema Patient Flow in UK

9A. Diabetic Macular Edema Prevalence in UK

9B. Diabetic Macular Edema Diagnosed Patients in UK

9C. Diabetic Macular Edema Treated Patients in UK

10. Diabetic Macular Edema Patient Flow in Japan

10A. Diabetic Macular Edema Prevalence in Japan

10B. Diabetic Macular Edema Diagnosed Patients in Japan

10C. Diabetic Macular Edema Treated Patients in Japan

For more information about this report visit

https://www.researchandmarkets.com/research/tncmhf/global_diabetic?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets